Coverage / PBLS / Trade Card

PBLS

Parabilis Medicines Inc

SPECULATIVE BUY 2026-08-08 Data 15 days old USD 34.98 AWAIT ENTRY
ACTIONABLEMethodology gates passed
43

Position levels

Currenttoday
USD 34.98
Buy <=wait / entry
USD 26.83
Trim >=take some off
USD 36.50
Thesis breakA failed pivotal or proof-of-concept readout from the zolucatetide programme, a ...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case8%100 / 1008.0
Base case49%62 / 10030.4
Bear case43%10 / 1004.3
Weighted conviction43 / 100 - SPECULATIVE BUY

Top risks

  • Clinical-stage biopharmaceutical company with no reported revenue (TTM)
  • Pipeline centered on zolucatetide targeting Wnt/?-catenin pathway in cancers
  • Raised $628M in funding from investors including Fidelity and RA Capital
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.